AstraZeneca $27B wipeout as Wainua late trial misses cardiovascular target
A failed late-stage heart study triggered a swift market punishment, forcing investors and boards to reset timelines and risk.

Curating from trusted global sources…
106 briefings · “ip”
A failed late-stage heart study triggered a swift market punishment, forcing investors and boards to reset timelines and risk.

GlobalData’s April CPMI shows resilience masking pre-execution caution, with conflict risk surfacing unevenly by country and sector.

The minister leading a review says England and Wales need changes to Personal Independence Payments.

In the middle of a high-stakes byelection week, Nigel Farage preemptively attacks the process oversight meant to scrutinize him.

Meta is moving deeper into AI coding with an upgrade led by its AI chief, sharpening the race against OpenAI and Anthropic.

The Quanta astronomer argues we need a probability-first search to stop “signals” from vanishing under scrutiny.

Multiple Bethesda employees tell IGN the cuts will hit long-term development, with knock-on effects across the project.

France’s captain flips reputations with a record-breaking run, turning old complaints into public apologies.

Alibaba, ByteDance, and DeepSeek can buy Nvidia H200 after China previously withheld approval despite US authorization.

What Nilekani’s move signals for Fundamentum’s AI and fintech push, leadership structure, and investors watching India’s startup market.

Unknown Worlds shipped Adaptive Measures, including violence tweaks and a stack of base-building improvements.

A gold-rush private market plus new restrictions is leaving investors competing for shares before any IPO.